Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04964115 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Post Acute Sequelae of COVID-19

Study acronym: PASC
StatusActive, Not Recruiting
PhaseNot specified
Started2021-08-10
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later May 31, 2026 → May 31, 2027
See other at-risk trials from Vanderbilt University Medical Center

Amendment history

2026-09-18
critical
Primary completion pushed: 2026-05-31 → 2027-05-31
Completion pushed: 2027-05-31 → 2028-05-31
2026-01-12
minor
Study Status, Eligibility v4
Primary completion date2026-05→2026-05-31
Completion date2027-05→2027-05-31
2024-06-06
notable
Recruiting→Active, Not Recruiting Study Status, Contacts/Locations v3
Trial statusRecruiting→Active, Not Recruiting
Study sitesdetails revised at 1 of 1 site
2022-11-17
minor
Study Status v2
Re-verified, no change to tracked fields
2021-10-11
minor
Study Status v1
Start dateestimated 2021-07-19→confirmed 2021-08-10
2021-07-13
minor
Original filing
COVID-19, a novel coronavirus, has caused widespread mortality and morbidity since it emerged in 2019. There is ongoing research and growing literature describing severe acute respiratory syndrome (SARS-COV-2). There is a growing population of individuals who have recovered from acute SARS-COV-2 infection. The long-term effects of COVID-19 are unknown. There are growing reports of sequelae after acute SARS-CoV-2 not limited to fatigue, dyspnea, reactive airway disease, organizing pneumonia, pulmonary fibrosis, pulmonary hypertension, pulmonary emboli, and tracheal disease. The incidence and natural history of these findings is unstudied.
Trial Details
NCT Number NCT04964115
Lead Sponsor Vanderbilt University Medical Center
Conditions Covid19, Sars-CoV-2 Infection, Dyspnea Caused by 2019-nCoV, COVID-19 Acute Respiratory Distress Syndrome, Pulmonary Fibrosis
Enrollment 500 participants
Start Date 2021-08-10
Primary Completion 2027-05-31 (estimated)
Study Completion 2028-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-09-17